497
Participants
Start Date
February 28, 2010
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
Cariprazine
Patients who meet eligibility criteria will be administered a once daily oral dose of cariprazine for three weeks. Upon completion of the study or early termination, patients will undergo a two week safety follow-up period.
Placebo
Patients who meet eligibility criteria will be administered a once daily oral dose of placebo for three weeks.
Forest Investigative Site 403, Belgrade
Forest Investigative Site 404, Belgrade
Forest Investigative Site 405, Belgrade
Forest Investigative Site 008, Cedarhurst
Forest Investigative Site 019, Philadelphia
Forest Investigative Site 007, Washington D.C.
Forest Investigative Site 006, Rockville
Forest Investigative Site 401, Senta
Forest Investigative Site 026, Atlanta
Forest Investigative Site 003, Orlando
Forest Investigative Site 402, Kragujevac
Forest Investigative Site 002, Kissimmee
Forest Investigative Site 314, Poltava
Forest Investigative Site 015, Memphis
Forest Investigative Site 021, Greenwood
Forest Investigative Site 308, Dnipropetrovsk
Forest Investigative Site 315, Dnipropetrovsk
Forest Investigative Site 011, Hoffman Estates
Forest Investigative Site 307, Kharkiv
Forest Investigative Site 310, Kharkiv
Forest Investigative Site 025, St Louis
Forest Investigative Site 302, Odesa
Forest Investigative Site 001, Shreveport
Forest Investigative Site 018, Little Rock
Forest Investigative Site 004, Irving
Forest Investigative Site 311, Lviv
Forest Investigative Site 301, Donetsk
Forest Investigative Site 012, Cerritos
Forest Investigative Site 306, Luhansk
Forest Investigative Site 005, Oceanside
Forest Investigative Site 023, San Diego
Forest Investigative Site 017, San Diego
Forest Investigative Site 010, Costa Mesa
Forest Investigative Site 024, Santa Ana
Forest Investigative Site 013, Honolulu
Forest Investigative Site 014, Bothell
Forest Investigative Site 503, Moscow
Forest Investigative Site 507, Moscow
Forest Investigative Site 510, Moscow
Forest Investigative Site 204, Târgovişte
Forest Investigative Site 506, Saint Petersburg
Forest Investigative Site 508, Saint Petersburg
Forest Investigative Site 201, Craiova
Forest Investigative Site 210, Craiova
Forest Investigative Site 502, Smolensk
Forest Investigative Site 211, Timișoara
Forest Investigative Site 209, Arad
Forest Investigative Site 501, Lipetsk
Forest Investigative Site 504, Saratov
Forest Investigative Site 509, Samara
Forest Investigative Site 212, Focşani
Forest Investigative Site 202, Constanța
Forest Investigative Site 016, New Britain
Forest Investigative Site 607, Rijeka
Forest Investigative Site 602, Zagreb
Forest Investigative Site 605, Zagreb
Forest Investigative Site 606, Zagreb
Forest Investigative Site 203, Bucharest
Forest Investigative Site 205, Bucharest
Forest Investigative Site 206, Bucharest
Forest Investigative Site 208, Bucharest
Forest Investigative Site 304, Kyiv
Forest Investigative Site 305, Kyiv
Forest Investigative Site 303, Kyiv
Forest Investigative Site 309, Kyiv
Forest Investigative Site 312, Kyiv
Lead Sponsor
Collaborators (1)
Gedeon Richter Ltd.
INDUSTRY
Forest Laboratories
INDUSTRY